Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
parking games
Popular Articles
Teeth Whitening Products

The Department Of Health And Human Services Teams Up With The White House And The Ad Council To Launch New Fatherhood Public Service Campaign
Just in time for Father"s Day weekend, the Secretary of Health and Human Services Kathleen Sebelius announced a new public service campaign today promoting fatherhood that features a PSA by President Obama. The campaign, sponsored by the department"s Administration for Children and Families and the Advertising Council, can be found at http://www.fatherhood.gov. The public service announcements and supporting campaign materials highlight the critical role fathers play in their children"s lives.
generic viagra online
The Downside Of Microtubule Stability - Study Shows Stalled Microtubules Might Be Responsible For Some Cases Of Charcot-Marie-Tooth Disease
Stalled microtubules might be responsible for some cases of the neurological disorder Charcot-Marie-Tooth (CMT) disease, Tanabe and Takei report in the June 15, 2009 issue of the Journal of Cell Biology. A mutant protein makes the microtubules too stable to perform their jobs, the researchers find.
News of the day
Power To The Veg! Go Veggie And Cut Cancer Risk
We all know that a diet rich in fruit and veg has huge health benefits, but recent research has shown that swapping to a vegetarian diet can actually cut your risk of cancer by 45%! Cutting out meat can also help you lose weight, detox your body and according to another study, make you feel healthier and happier!
Health Insurance

Mylan Receives FDA Approval For Generic Version Of Prostate Cancer Treatment Casodex(R)

Mylan Inc. (Nasdaq: MYL) announced that its subsidiary Mylan Pharmaceuticals Inc. has received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Bicalutamide Tablets, 50 mg. Bicalutamide Tablets are the generic version of AstraZeneca"s prostate cancer treatment Casodex(R), which had total U.S. sales of approximately $322 million for the 12 months ending March 31 for the same strength, according to IMS Health. Mylan has begun to ship this product. Currently, Mylan has 118 ANDAs pending FDA approval representing $82.8 billion in annual brand sales, according to IMS Health. Thirty-five of these pending ANDAs are potential first-to-file opportunities, representing $16.7 billion in annual brand sales, according to IMS Health. Mylan Inc., which provides products to customers in more than 140 countries and territories, ranks among the leading diversified generics and specialty pharmaceutical companies in the world. The company maintains one of the industry"s broadest -- and highest quality -- product portfolios, supported by a robust product pipeline; owns a controlling interest in the world"s third largest active pharmaceutical ingredient manufacturer; and operates a specialty business focused on respiratory and allergy therapies. Mylan Inc


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009